The drug Bronchitol has been approved for marketing in Russia following new Russian laws that provide patients access to innovative medicines, Pharmaxis announced to the ASX on Tuesday. Bronchitol will be manufactured and exported to Russia from Pharmaxis' Sydney factory with the first sales expected before the end of 2016.
